Mode
Text Size
Log in / Sign up
N/A N=151 Randomized Treatment

Stress Management and Biomarkers of Risk in Cardiac Rehabilitation

Coronary Heart Disease

Enrolled (actual)
151
Serious AEs
0.0%
Results posted
Jan 2018
Primary outcome: Primary: Absolute Composite Stress Score — 77.6; 67.5 Mean rank score

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SMT-enhanced Cardiac Rehabilitation (Behavioral); Standard Cardiac Rehabilitation (Behavioral)
Age
Adult, Older Adult · 35+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Jul 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Absolute Composite Stress Score
77.6; 67.5
PRIMARY
Change From Baseline to 12 Weeks in Individual Scaled Scores
-3.5; -2.6; -5.6; -2.6; -4.8; -3.3 <0.05 sig
SECONDARY
Major Adverse Cardiovascular Events (MACE) - All Cause Death, MI, Cardiac Revascularization and Cardiovascular Hospitalization.
0; 2; 1; 6; 9; 11
SECONDARY
Change in High-sensitivity C-Reactive Protein
-0.9; -0.4 .95
SECONDARY
Heart Rate Variability During Controlled Breathing (HRV-DB)
13.1; 26.0 0.99
SECONDARY
Baroreflex Sensitivity
0.47; 0.93 0.99
SECONDARY
Heart Rate Variability During Rest
0.17; 0.28; 0.08; 0.22 0.99

Summary

The purpose of this study is to assess the extent to which combining exercise and stress management training (SMT) is more effective at improving biomarkers in vulnerable cardiac patients compared to exercise-based cardiac rehabilitation alone.

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Coronary Heart Disease (CHD)
  • Eligibility for Cardiac Rehabilitation (CR) in North Carolina
  • Capacity to give informed consent and follow study procedures

Exclusion Criteria

  • Received heart transplant
  • LVEF 200/120 mm Hg
  • Left main disease > 50%
  • Unable to comply with assessment procedures
  • Unwilling or unable to be randomized to treatment groups
  • Primary diagnosis of the following psychiatric disorders: schizophrenia, dementia, current delirium, or other psychotic disorder
  • Current alcohol or substance abuse disorder
  • Acute suicide risk
  • Actively undergoing ongoing psychiatric treatment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00981253). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search